# Phase 5 Final Audit & Pre-Phase-6 Release Gate

**Project Title:** “A YOLOv8-Based Framework for Automated Coconut Tree Disease Detection and Plantation Health Monitoring Using Mobile Applications”  
**Project Directory:** `C:\Users\Hp\.gemini\antigravity-ide\scratch\coconut-disease-yolov8`  
**Audit Timestamp:** 2026-09-20T04:55:00 UTC  
**Auditor Role:** Senior ML / Research Engineering Lead  

---

## 1. Executive Overview

This document establishes the official audit record and release-gate decision for **Phase 5 — Plantation Health Monitoring Engine**.

The primary objective of this audit was to:
1. Thoroughly inspect all Phase 5 modules, tests, scripts, and numerical outputs.
2. Resolve a known validator/reporting count inconsistency where the report printed `11 / 10`.
3. Add regression protection against future validator accounting defects.
4. Verify that Phase 3 model checkpoints and Phase 4 test evaluation artifacts were 100% protected and untouched.
5. Determine whether Phase 5 satisfies all scientific and engineering requirements to pass the release gate.

---

## 2. Validator Audit & Correction

### Issue Root Cause
The validator script `scripts/validate_health_monitoring.py` executed 11 distinct checks across schema integrity, geometry, probability bounds, numerical stability, internal aggregation consistency, and deterministic reproducibility. However, the print statement's denominator was statically hardcoded to `10` from an earlier draft schema, causing the output `Total Checks Passed: 11 / 10`.

### Resolution Implemented
* **Dynamic Check Registration**: Refactored `HealthMonitoringValidator` in `scripts/validate_health_monitoring.py` to register all checks dynamically in `self.checks`.
* **Dynamic Accounting Metrics**:
  * `total_checks = len(self.checks)` (dynamically evaluated as 11)
  * `passed_checks = sum(1 for r in results if r['passed'])`
  * `failed_checks = total_checks - passed_checks`
* **Invariant Assertions**: The validator explicitly enforces the following structural guarantees before emitting results:
  * `passed_checks + failed_checks == total_checks`
  * `passed_checks <= total_checks`
  * `failed_checks >= 0`

### Validator Execution Telemetry
```text
======================================================================
PHASE 5 PLANTATION HEALTH MONITORING VALIDATION RESULTS
======================================================================
Total Checks Executed: 11
Total Checks Passed:   11 / 11
Total Checks Failed:   0 / 11
======================================================================
  [PASS] Report Schema Completeness: All required top-level report keys present.
  [PASS] Record Schema Completeness: All image records contain required schema fields.
  [PASS] Disease Class Integrity: All detected classes match valid coconut disease ontology.
  [PASS] Confidence Bounds [0,1]: All confidence scores strictly bounded in [0.0, 1.0].
  [PASS] Bounding Box Coordinates: All bounding box coordinates are non-negative and properly oriented.
  [PASS] Area Proxy Bounds [0,1]: All Relative Affected Area Proxies bounded in [0.0, 1.0].
  [PASS] Percentage Bounds [0,100]: All percentage values bounded in [0.0, 100.0].
  [PASS] Numerical Stability: No NaNs, Infs, or unhandled numeric anomalies detected.
  [PASS] Observation Count Consistency: Image-level observation statuses match aggregated counts exactly.
  [PASS] Detection Count Consistency: Total accepted detection counts match across records and distribution.
  [PASS] Deterministic Aggregation: Repeated aggregation produces bitwise identical PHI scores.
======================================================================
All 11 validation checks passed with 100% precision.
No negative areas, no impossible percentages, no division-by-zero.
Deterministic aggregation and internal consistency VERIFIED.

FINAL STATUS: PASS
======================================================================
```

* **Validator Checks Executed**: 11
* **Validator Checks Passed**: 11 / 11
* **Validator Checks Failed**: 0
* **Count Consistency**: **VERIFIED (11 / 11, Invariants Enforced)**

---

## 3. Unit Tests & Regression Protection

The unit test suite in `tests/test_health_monitoring.py` was extended to include regression protection (`test_validator_accounting_invariants`).

### Test Coverage (13 Tests):
1. `test_iou`: Bounding box IoU mathematical accuracy.
2. `test_bounding_box_area`: Area calculations under normal, zero, and inverted coordinates.
3. `test_overlap_handling`: Sweep-line union area eliminating double counting on identical, disjoint, and nested boxes.
4. `test_disease_counting`: Exact multi-image lesion counting.
5. `test_image_level_aggregation`: Observation totals and submission tracking.
6. `test_disease_distribution`: Decoupling proof showing $N_{\text{det}} \ne N_{\text{tree}}$.
7. `test_health_index_calculation`: PHI incidence and composite formulas vs. manual calculation.
8. `test_empty_detections`: All-healthy blocks evaluate to 100% PHI and `EXCELLENT` tier.
9. `test_low_confidence_detections`: Candidates in $[0.10, 0.25)$ do not inflate confirmed counts.
10. `test_invalid_boxes`: Validation rejects malformed, inverted, or $>1.0$ confidence boxes.
11. `test_multiple_diseases_in_one_image`: Proper multi-class co-infection handling.
12. `test_repeated_observations`: Longitudinal multi-visit tracking across successive dates.
13. `test_validator_accounting_invariants`: **(New Regression Protection)** Verifies `passed + failed == total`, `passed <= total`, `failed >= 0`, and catches simulated out-of-bounds confidence injection.

### Execution Output
```text
$ python -m unittest discover tests
.............
----------------------------------------------------------------------
Ran 13 tests in 0.019s

OK
```
* **Total Unit Tests**: 13
* **Passed**: 13
* **Failed**: 0
* **Errors**: 0

---

## 4. Research Integrity Audit

### Phase 3 Artifact Protection
Verified cryptographic SHA-256 hashes and byte lengths of Phase 3 model checkpoints:
* `outputs/training/EXP-001_baseline_yolov8n/weights/best.pt`:
  * Size: 6,229,930 bytes | SHA-256: `63010fd24ee38cb0...`
  * Status: **UNTOUCHED & PROTECTED**
* `outputs/training/EXP-002_imgsz512/weights/best.pt`:
  * Size: 6,218,538 bytes | SHA-256: `e3b2b5d39f1e6bce...`
  * Status: **UNTOUCHED & PROTECTED**

### Phase 4 Evaluation Artifact Protection
Verified integrity of Phase 4 test set evaluation outputs:
* `outputs/evaluation/phase_4_test_results.json`: 22,359 bytes | SHA-256: `1168872079d6a130...` (**UNTOUCHED**)
* `outputs/evaluation/phase_4_per_class_results.csv`: 675 bytes | SHA-256: `bb77de672ff6d6aa...` (**UNTOUCHED**)
* `outputs/evaluation/phase_4_error_registry.csv`: 4,979 bytes | SHA-256: `091c978fab9ec27b...` (**UNTOUCHED**)
* `outputs/evaluation/detection_output_schema.json`: 2,837 bytes | SHA-256: `30fc4ec1ae4059a8...` (**UNTOUCHED**)

### Experimental Integrity Verification
* **No Test-Set Threshold Tuning**: The operational threshold ($\tau_{\text{op}} = 0.25$) was preserved as an engineering baseline; no tuning was conducted on the Phase 4 test set.
* **No Fabricated Annotations / Detections**: All numbers in Phase 5 originate from real model inference or exact mathematical formulas.
* **No Unsupported Clinical Claims**: The 2D area proxy is explicitly defined as a geometric visual proxy in camera space, not biological tissue necrosis.
* **No Regional Prevalence Extrapolation**: Observation rates are explicitly documented as sample-level statistics from the 35 submitted validation photographs.

---

## 5. Mathematical & Output Integrity

### Verified Formulations
1. **Bounding Box Overlap (Klee's Measure 2D Sweep-Line)**:
   $$A_{\text{union}} = \bigcup_{k=1}^K B_k = \sum_{p=1}^{P-1} (x_{(p+1)} - x_{(p)}) \cdot \text{MergedLength}\left(\{ [y_1^{(k)}, y_2^{(k)}] \mid B_k \text{ spans } [x_{(p)}, x_{(p+1)}] \}\right)$$
   Guarantees zero double counting of overlapping lesions; strictly bounded in $[0.0, 1.0]$.
2. **Relative Affected Area Proxy**:
   $$A_{\text{proxy}} = \frac{A_{\text{union}}}{W_{\text{img}} \times H_{\text{img}}} \in [0.0, 1.0]$$
3. **Decoupled Disease Distribution**:
   $N_{\text{det}} = 6 \ne N_{\text{tree}} = 3$ on Model B validation demonstration run.
4. **Plantation Health Index**:
   * $\text{PHI}_{\text{incidence}} = 100 \times (1.0 - M_{\text{pos}} / M_{\text{valid}}) = 91.43 / 100$
   * $\text{PHI}_{\text{composite}} = 100 \times (1.0 - [0.85 \cdot (M_{\text{pos}} / M_{\text{valid}}) + 0.15 \cdot \overline{A_{\text{proxy}}}]) = 92.12 / 100$
   * Weights $w_1 = 0.85, w_2 = 0.15$ and thresholds $\tau = 0.25$ verified unchanged.

### Output Files Integrity
The following 5 target files in `outputs/health_monitoring/` were inspected and verified:
* `image_health_records.json` (36,081 bytes)
* `plantation_health_report.json` (3,496 bytes)
* `plantation_health_report.csv` (1,237 bytes)
* `disease_distribution.csv` (266 bytes)
* `model_comparison.json` (1,462 bytes)

All outputs are completely consistent and have not been needlessly regenerated.

---

## 6. Known Limitations

The following scientific limitations are explicitly preserved:
1. **Sample Statistics vs. True Epidemiological Prevalence**: Observation rates reflect submitted photo samples and do not represent formal epidemiological prevalence without random spatial grid sampling.
2. **Visual Area Proxy vs. Clinical Staging**: $A_{\text{proxy}}$ measures visible 2D bounding box area in the camera frame; it does not replace in-situ plant pathology tissue depth grading.
3. **Quantities Not Computable from Current Dataset**:
   * *True plantation-wide disease prevalence*: Requires full palm census and random spatial coordinate sampling.
   * *Clinical lesion necrosis depth*: Requires destructive botanical tissue sampling.
   * *Agronomic yield loss / economic impact*: Requires longitudinal harvest yield logs over multiple fruiting cycles.

---

## 7. Final Release Gate

| Audit Criterion | Verification Status | Notes |
| :--- | :---: | :--- |
| **Validator Implementation & Invariants** | **PASS** | 11 / 11 checks passed; invariants strictly enforced |
| **Unit Test Suite & Regression Protection** | **PASS** | 13 / 13 passed in 0.019s |
| **Phase 3 Model Checkpoint Protection** | **PASS** | `best.pt` files untouched and verified by SHA-256 |
| **Phase 4 Evaluation Artifact Protection** | **PASS** | All test results and error registries untouched |
| **Mathematical Formulation Integrity** | **PASS** | Exact formulas verified; no weight/threshold tuning |
| **Output Consistency & Formats** | **PASS** | JSON, CSV, and model comparison verified intact |
| **Research Integrity & Defensible Terminology**| **PASS** | No clinical or regional prevalence claims made |

### Final Release Gate Decision:
# **PASS**

Phase 5 is officially certified as complete, mathematically sound, reproducible, and ready for Phase 6.

---

## 8. Explicit Phase Boundary Statement

**PHASE 6 WAS STRICTLY NOT STARTED.**  
In accordance with research instructions:
* No mobile application code (Flutter, React Native, Android/iOS) was generated.
* No edge model conversion (ONNX, TFLite, CoreML) was performed.
* No mobile hardware latency benchmarking was executed.
* No APIs or deployment servers were created.
